When we analyzed the serum of postmenopausal women shortly before breast cancer diagnosis or matched sera from women before and after clinical manifest breast cancer, we observed reduced RANKL and increased OPG serum levels. This evidence concerns the gene TNFRSF11B and breast carcinoma.